DYADIC INTERNATIONAL INC (DYAI)

↓ Download CSV

CIK 0001213809 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, DYADIC INTERNATIONAL INC reported revenue of $3.09M, down 11.6% from the prior year. The company ran a net loss, with a net margin of -238.3%. It held $9.95M in total assets against $8.71M in total liabilities.

Key ratios (FY2025)

-232.8%
Operating margin
-238.3%
Net margin
-597.6%
Return on equity
-11.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$3.09M$3.50M$2.90M$2.93M$2.40M$1.60M$1.68M$1.30M$758.4K
Cost of Revenue$2.32M$1.19M$1.98M$2.12M$1.94M$1.42M$1.46M$1.03M$680.2K
Operating Income-$7.19M-$5.90M-$8.23M-$10.17M-$14.73M-$10.03M-$9.28M-$7.59M-$7.13M
Net Income-$7.36M-$5.81M-$6.80M-$9.74M-$13.07M-$9.33M-$8.31M-$5.69M-$2.14M
EPS (Diluted)$-0.23$-0.20$-0.24$-0.34$-0.47
Total Assets$9.95M$9.93M$8.22M$13.71M$21.30M$30.07M$37.45M$43.30M$50.74M
Total Liabilities$8.71M$7.46M$2.34M$2.63M$2.91M$1.63M
Shareholders' Equity$1.23M$2.47M$5.88M$11.09M$18.39M$28.45M$35.86M$42.45M$49.98M$57.69M
Cash & Equivalents$4.62M$6.51M$6.52M$5.79M$15.75M$20.64M$4.82M$2.39M$5.79M
Operating Cash Flow-$5.70M-$3.97M-$6.73M-$8.08M-$11.28M-$6.57M-$5.78M-$4.41M-$1.69M
Shares Outstanding36.19M29.84M28.81M28.56M28.23M27.49M27.36M26.71M28.33M